Sheltagen Medical

Company Overview

Snapshot

Founded in December 2009 by Nahum Rosenberg, Sheltagen Medical operates with 1–10 employees. The company focuses on developing human bone tissue for implantation and holds a patent in this field.

Business overview

Sheltagen Medical specializes in developing autologous bone grafts for orthopedic and dental surgery. The company's core technology involves producing patient-specific human bone tissue using the patient's own bone cells and blood components, thereby minimizing rejection risk. This methodology includes seeding autologous bone cells on an inorganic matrix, culturing them in media with self-blood serum, and applying mechanical stimulation through vibration. Sheltagen Medical serves the global healthcare market, specifically targeting providers within the medical devices, medical treatment, therapeutics, and biomaterials & tissue engineering sectors.

Company Intelligence Q&A

What is Sheltagen Medical's primary focus?

Sheltagen Medical focuses on developing autologous bone grafts for orthopedic and dental surgery, utilizing a patient's own bone cells and blood components to create implantable human bone tissue.

Who founded Sheltagen Medical?

Sheltagen Medical was founded by Nahum Rosenberg, who also serves as its CEO.

When was Sheltagen Medical founded?

Sheltagen Medical was founded in December 2009.

What is Sheltagen Medical's current funding stage?

Sheltagen Medical is currently in the Pre-Funding stage.

Does Sheltagen Medical hold any patents?

Yes, Sheltagen Medical holds a patent related to its bone tissue development technology.